Neoleukin Therapeutics (NLTX) Earnings Date, Estimates & Call Transcripts

$30.49
-1.09 (-3.45%)
(As of 04/19/2024)
Skip Charts & View Estimated and Actual Earnings Data

NLTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NLTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Neoleukin Therapeutics Analyst EPS Estimates

Current Year EPS Consensus Estimate:($3.25) EPS

Neoleukin Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/14/2023Q3 2023($3.20)($1.64)+$1.56($0.41)--
8/10/2023Q2 2023($3.00)($0.80)+$2.20($0.04)--
5/8/2023Q1 2023($3.60)($4.00)($0.40)($0.14)--
3/21/2023Q4 2022-($4.80)($4.80)($0.24)--
11/14/2022Q3 2022($6.40)($4.80)+$1.60($0.24)--
8/9/2022Q2 2022($6.00)($5.60)+$0.40($0.28)--
5/9/2022Q1 2022($6.00)($5.60)+$0.40($0.28)--
3/1/2022Q4 2021($6.00)($5.60)+$0.40($0.28)--
11/4/2021Q3 2021($5.60)($5.60)-($0.28)--
8/5/2021Q2 2021($5.20)($5.40)($0.20)($0.27)--
5/13/2021Q1 2021($4.60)($5.40)($0.80)($0.27)--  

Neoleukin Therapeutics Earnings - Frequently Asked Questions

How much profit does Neoleukin Therapeutics generate each year?

Neoleukin Therapeutics (NASDAQ:NLTX) has a recorded net income of -$57.56 million. NLTX has generated -$3.11 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (NASDAQ:NLTX) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners